The survey, which is being carried out throughout June, was also conducted back in 2016 and is now being repeated to identify any developments and outcomes that have been made over the past four years, a time in which several new epilepsy management options have emerged.
The survey asks vets to prioritise how important they feel different areas of epilepsy research are and assess how much they think new therapies might improve epileptic dogs’ lives. This includes emerging therapies like MCT oil, cannabidiol oil, vagus nerve stimulation and transcranial magnetic stimulation, for which studies are currently being conducted across the globe.
The aim of the survey is to identify the priorities for future research for owners, vets and neurologists alike, and to see if there are any differences in their priorities.
Dr Rowena Packer, BBSRC Research Fellow and research lead in canine epilepsy at the RVC, said: "This survey was inspired by similar prioritisation activities undertaken by the International League Against Epilepsy (ILAE) for human epilepsy patients. At the RVC, we believe that the benefits of such an open approach can be truly valuable for veterinary medicine too, and ensure a diversity of views influence future epilepsy priorities."
Dr Gareth Jones, Small Animal Intern at the RVC who is running the study, said: "While many have already undertaken the survey, we are keen to hear from more participants so I would like to implore any general practice vets to please help contribute to our work by taking part in our short survey."
To take part in this survey please visit www.rvc.uk.com/epilepsy-future, and do share this news story with colleagues. If you have any questions about the research, e-mail Dr Gareth Jones atgjones1@rvc.ac.uk.
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.